Clinical trials using Omicron-specific vaccinations are now underway, but no data on human participants has been released. Meanwhile, the FDA wants to move COVID vaccines to a flu like model.
Officials from the Food and Drug Administration (FDA) have suggested a future paradigm for producing new COVID-19 vaccinations based on the method used to produce influenza vaccines.
The existing COVID-19 vaccinations, which are based on a virus strain that is now many generations old, "may need ...
